Pulmonx Corporation logo

Pulmonx Corporation (LUNG)

Market Closed
10 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 85
-0.13
-6.5657%
Pre Market
$
1. 95
+0.1 +5.4054%
87.85M Market Cap
- P/E Ratio
- Div Yield
479,328 Volume
-1.65 Eps
$ 1.98
Previous Close
Add Transaction
Day Range
1.82 1.91
Year Range
1.13 2.89
Want to track LUNG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pulmonx Corporation (LUNG) Statistics

Valuation metrics

Market Cap 87.85M
Enterprise value 93.71M
Trailing P/E (ttm) -1.92
Forward P/E -1.42
PEG ratio -0.09
Price/Sales (ttm) 1.07
Price/Book (mrq) 2.38
Enterprise Value/Revenue 1.07
Enterprise Value/EBITDA -2.18

Overview

Shares outstanding 42.24M
Float 37.27M
Shares short 3.56M
% Held by insiders 0.05%
% Held by institutions 0.78%
Average volume (10 days) 213.51K
Average volume (90 days) 1.05M

Price summary

52-Week low 1.13
52-Week high 2.89
Beta 0.18
50-Day moving average 1.94
200-Day moving average 1.46

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.55%
Operating margin -0.53%

Operational effectiveness

Return on assets -0.42%
Return on equity -0.97%

Income Statement

Revenue (ttm) 88.55M
Revenue per share (ttm) 2.07
Quarterly revenue growth (yoy) -0.09%
Gross profit (ttm) 66.84M
EBITDA -51.16M
Net income to common (ttm) -53.21M
Diluted EPS (ttm) -1.14
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 61.57M
Total cash per share (mrq) 1.32
Total debt (mrq) 56.29M
Total Debt/Equity (mrq) 1.43
Current ratio (mrq) 4.32%
Book value per share (mrq) 0.93

Cash Flow

Cash flow statement -29.25M
Levered free cash flow (LFCF) -8.36M